3rd Annual ALS Drug Development Summit (ALS DDS) 2024 | May 21-23, 2023
May 21, 2024 — Reda et al.
ATH-1105, a small-molecule positive modulator of the neurotrophic HGF system, attenuates TDP-43 pathology in preclinical models of ALS
May 21, 2024 — Berthiaume et al.
ATH-1105, a smallmolecule targeting the neurotrophic HGF system, is neuroprotective and prolongs survival in the Prp-TDP43A315T mouse model of ALS
